10% Off
Famomax50 ml
Beximco Pharmaceuticals Ltd.
৳45.00
Add to cart
Famotack50 ml
Powder for Suspension
By
Best PriceTk /
1
Alternatives
Price
Medicine overview
Indications of Famotack 50 ml
Famotack 50 ml is indicated in-
Gastric ulcer
Duodenal ulcer
Anastomotic ulcer
Acute stress ulcer
Reflux esophagitis and
Zollinger-Ellison syndrome.
Famotack 50 ml is also indicated for the treatment of acute gastritis, chronic gastritis in the acute exacerbation stage.
Theropeutic Class
H2 receptor antagonist
Pharmacology
Famotack 50 ml is a histamine H2-receptor antagonist.
Absorption
It inhibits basal, overnight and pentagastrin stimulated gastric acid secretion.
Distribution
The H2-receptor antagonist activity of Famotack 50 ml is slowly reversible, since the drug dissociates slowly from H2-receptor.
Dosage & Administration of Famotack 50 ml
Duodenal ulcer
Dosage:40 mg at night for 4 to 8 weeksBenign gastric ulcer: 40 mg at night for 4 to 8 weeks; Maintenance therapy: 20 mg at night for preventing the recurrences of duodenal ulcerationGastro-oesophageal reflux disease: 20 mg twice daily for 6 to 12 weeksZollinger Ellison syndrome: The recommended starting dose is 20 mg every six hours
Notes:Dosage should then be adjusted to individual response. Doses up to 160 mg every six hours have been administered to some patients without the development of significant adverse effectsDosage can be administered irrespective of meals. Antacids may be given concomitantly if needed
| Condition | Dosage | Notes |
|---|---|---|
| Duodenal ulcer | 40 mg at night for 4 to 8 weeksBenign gastric ulcer: 40 mg at night for 4 to 8 weeks; Maintenance therapy: 20 mg at night for preventing the recurrences of duodenal ulcerationGastro-oesophageal reflux disease: 20 mg twice daily for 6 to 12 weeksZollinger Ellison syndrome: The recommended starting dose is 20 mg every six hours | Dosage should then be adjusted to individual response. Doses up to 160 mg every six hours have been administered to some patients without the development of significant adverse effectsDosage can be administered irrespective of meals. Antacids may be given concomitantly if needed |
Dosage of Famotack 50 ml
Tablet
Dosage:For gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastro-intestinal hemorrhage, reflux esophagitis and Zollinger-Ellison syndrome: Usual dose for adults: Famotack 50 ml 20 mg twice daily (after breakfast and after supper or before bed time) or Famotack 50 ml 40 mg can be administered orally once daily at bed time
Notes:For the treatment of acute gastritis, chronic gastritis in acute exacerbation stage: Usual dosage for adults is Famotack 50 ml 20 mg orally twice a day (after breakfast and after supper or before bed time). Also Famotack 50 ml 40 mg can be orally administered once a day (before bed time), dosage should be adjusted according to age and symptoms. Most ulcer patients heal within 4-8 weeks. For maintenance therapy the recommended oral dose is 20 mg once daily. Or, as directed by the registered physician
Powder for Suspension
Dosage:Gastroesophageal Reflux Disease(GERD): <1 year of age: 0.5 mg/kg/dose of Famotack 50 ml oral suspension up to 8 weeks once daily in patients Age 3 to 11 months: 0.5 mg/kg/dose twice daily up to 8 weeks Age 1 to 2 months: 0.5 mg/kg/dose once daily up to 8 weeks Neonates: 0.5 mg/kg/dose maximum once daily up to 8 weeks Patients 1-16 years of age: Gastroesophageal Reflux Disease(GERD): 1 mg/kg/day p
Notes:divided b. up to 40 mg b
Duodonal ulcer
Dosage:0.5 mg/kg/day p
Notes:at bedtime or divided b. up to 40 mg/day
Peptic ulcer
Dosage:0.5 mg/kg/day p
Notes:at bedtime or divided b. up to 40 mg/day
Maintenance therapy
Dosage:40 mg at daily night
Reflux esophagitis
Dosage:2 mg/kg/day Zollinger-Ellison Syndrome: 40 mg 3 times daily
Intravenous Injection
Dosage:In some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or in patients who are unable to take oral medication, Famotack 50 ml Injection Premixed or Famotack 50 ml Injection may be administered until oral therapy can be instituted
Notes:The recommended dosage for Famotack 50 ml Injection Premixed and Famotack 50 ml Injection in adult patients is 20 mg intravenously q 12 h. The doses and regimen for parenteral administration in patients with GERD have not been established
Dosage for Pediatric Patients
Dosage:Pediatric Patients suggest that the starting dose in pediatric patients 1-16 years of age is 0.25 mg/kg intravenously (injected over a period of not less than two minutes or as a 15-minute infusion) q 12 h up to 40 mg/day
Notes:While published uncontrolled clinical studies suggest the effectiveness of Famotack 50 ml in the treatment of peptic ulcer, data in pediatric patients are insufficient to establish percent response with dose and duration of therapy. Therefore, treatment duration (initially based on adult duration recommendations) and dose should be individualized based on clinical response and/or gastric pH determination and endoscopy. Published uncontrolled studies in pediatric patients have demonstrated gastric acid suppression with doses up to 0.5 mg/kg intravenously q 12 h. No pharmacokinetic or pharmacodynamic data are available on pediatric patients under 1 year of age
| Condition | Dosage | Notes |
|---|---|---|
| Tablet | For gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastro-intestinal hemorrhage, reflux esophagitis and Zollinger-Ellison syndrome: Usual dose for adults: Famotack 50 ml 20 mg twice daily (after breakfast and after supper or before bed time) or Famotack 50 ml 40 mg can be administered orally once daily at bed time | For the treatment of acute gastritis, chronic gastritis in acute exacerbation stage: Usual dosage for adults is Famotack 50 ml 20 mg orally twice a day (after breakfast and after supper or before bed time). Also Famotack 50 ml 40 mg can be orally administered once a day (before bed time), dosage should be adjusted according to age and symptoms. Most ulcer patients heal within 4-8 weeks. For maintenance therapy the recommended oral dose is 20 mg once daily. Or, as directed by the registered physician |
| Powder for Suspension | Gastroesophageal Reflux Disease(GERD): <1 year of age: 0.5 mg/kg/dose of Famotack 50 ml oral suspension up to 8 weeks once daily in patients Age 3 to 11 months: 0.5 mg/kg/dose twice daily up to 8 weeks Age 1 to 2 months: 0.5 mg/kg/dose once daily up to 8 weeks Neonates: 0.5 mg/kg/dose maximum once daily up to 8 weeks Patients 1-16 years of age: Gastroesophageal Reflux Disease(GERD): 1 mg/kg/day p | divided b. up to 40 mg b |
| Duodonal ulcer | 0.5 mg/kg/day p | at bedtime or divided b. up to 40 mg/day |
| Peptic ulcer | 0.5 mg/kg/day p | at bedtime or divided b. up to 40 mg/day |
| Maintenance therapy | 40 mg at daily night | |
| Reflux esophagitis | 2 mg/kg/day Zollinger-Ellison Syndrome: 40 mg 3 times daily | |
| Intravenous Injection | In some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or in patients who are unable to take oral medication, Famotack 50 ml Injection Premixed or Famotack 50 ml Injection may be administered until oral therapy can be instituted | The recommended dosage for Famotack 50 ml Injection Premixed and Famotack 50 ml Injection in adult patients is 20 mg intravenously q 12 h. The doses and regimen for parenteral administration in patients with GERD have not been established |
| Dosage for Pediatric Patients | Pediatric Patients suggest that the starting dose in pediatric patients 1-16 years of age is 0.25 mg/kg intravenously (injected over a period of not less than two minutes or as a 15-minute infusion) q 12 h up to 40 mg/day | While published uncontrolled clinical studies suggest the effectiveness of Famotack 50 ml in the treatment of peptic ulcer, data in pediatric patients are insufficient to establish percent response with dose and duration of therapy. Therefore, treatment duration (initially based on adult duration recommendations) and dose should be individualized based on clinical response and/or gastric pH determination and endoscopy. Published uncontrolled studies in pediatric patients have demonstrated gastric acid suppression with doses up to 0.5 mg/kg intravenously q 12 h. No pharmacokinetic or pharmacodynamic data are available on pediatric patients under 1 year of age |
Interaction of Famotack 50 ml
No clinically important drug interactions have been identified. Famotack 50 ml does not interact with the cytochrome P450-linked drug-metabolizing enzyme system.
Contraindications
Known hypersensitivity to any component of the drug.
Side Effects of Famotack 50 ml
Eruption, constipation, diarrhoea, dry mouth, nausea, vomiting, tachycardia, high blood pressure, headache, drowsiness or insomnia may rarely occur.
Pregnancy & Lactation
Pregnancy: There are no adequate, well controlled studies on Famotack 50 ml in pregnancy, but it is known to cross the placenta and should be prescribed only if clearly needed.Lactation: It is not known whether Famotack 50 ml is secreted into human milk, nursing mothers should either stop nursing or stop taking the drug.
Precautions & Warnings
The drug should be used in the minimum required amount depending upon the conditions of the diseases. The drug should be administered carefully with elderly patients, patients with renal failure and hepatic disorders.
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Mode Of Action
Famotack 50 ml is a histamine H2-receptor antagonist. Famotack 50 ml completely inhibits the action of histamine on H2- receptors of parietal cell. It inhibits basal, overnight and pentagastrin stimulated gastric acid secretion. The H2- receptor antagonist activity of Famotack 50 ml is slowly reversible, since the drug dissociates slowly from H2-receptor.
Pregnancy
Pregnancy category B. There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Caution should be exercised when Famotid is administered to a nursing woman.
Frequently Asked Questions
What is Famotack 50 ml used for?
Famotidine is indicated in- Gastric ulcer Duodenal ulcer Anastomotic ulcer Acute stress ulcer Reflux esophagitis and Zollinger-Ellison syndrome. Famotidine is also indicated for the treatment of acute gastritis, chronic gastritis in the acute exacerbation stage.
What is the dosage of Famotack 50 ml?
Tablet: For gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastro-intestinal hemorrhage, reflux esophagitis and Zollinger-Ellison syndrome: Usual dose for adults: Famotidine 20 mg twice daily (after breakfast and after supper or before bed time) or Famotidine 40 mg can be administered orally once daily at bed time. For the treatment of acute gastritis, chronic gastritis in acute exacerbat…
What are the side effects of Famotack 50 ml?
Eruption, constipation, diarrhoea, dry mouth, nausea, vomiting, tachycardia, high blood pressure, headache, drowsiness or insomnia may rarely occur.
Who should not take Famotack 50 ml?
Known hypersensitivity to any component of the drug.
What precautions should be taken with Famotack 50 ml?
The drug should be used in the minimum required amount depending upon the conditions of the diseases. The drug should be administered carefully with elderly patients, patients with renal failure and hepatic disorders.
Is Famotack 50 ml safe during pregnancy and breastfeeding?
Pregnancy: There are no adequate, well controlled studies on Famotidine in pregnancy, but it is known to cross the placenta and should be prescribed only if clearly needed.Lactation: It is not known whether Famotidine is secreted into human milk, nursing mothers should either stop nursing or stop taking the drug.
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.